BIO-109

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBIO-109

Drug Alias NameBIO-109

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRibonucleotide reductase inhibitors

TargetsRibonucleotide reductase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEvolve Oncology

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEvolve Oncology

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A